Abstract
A randomized controlled fixed-dose trial of olanzapine for psychosis in Parkinson disease Michelle J Nichols, Washington University School of Medicine in St. Louis Johanna M Hartlein, Washington University School of Medicine in St. Louis Meredith G Albin, Washington University School of Medicine in St. Louis Bradley A Racette, Washington University School of Medicine in St. Louis Kevin J Black, Washington University School of Medicine in St. Louis
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
